Premium
Autoradiography of non‐AT‐1, non‐AT‐2 125‐I‐SI angiotensin II binding in neurolysin knock‐out and wild‐type mouse brains
Author(s) -
Speth Robert C,
Santos Kira L,
Swindle Jamala D.,
Reiley Luz Gonzalez,
Linares Andrea,
Schadock Ines,
Bader Michael,
Karamyan Vardan T
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.1093.10
Subject(s) - olfactory bulb , medicine , angiotensin ii , hippocampus , chemistry , endocrinology , striatum , nucleus accumbens , substantia nigra , cerebellum , olfactory tubercle , binding site , radioligand , cerebral cortex , receptor , biology , central nervous system , biochemistry , dopamine , dopaminergic
Recently a novel, non‐AT 1 , non‐AT 2 binding site for angiotensin II (Ang II) was identified as the metalloendopeptidase neurolysin. To assess the localization of this binding site in brain, 3 mice deficient in neurolysin and 3 wild‐type mouse brains were evaluated for radioligand binding with 125 I‐Sar 1 , Ile 8 Ang II (250 pM) in the presence of AT 1 and AT 2 receptor‐saturating concentrations of losartan and PD123319, and 150 μM p‐chloromercuribenzoate using in vitro autoradiography. Specific (10 μM Ang II displaceable) 125 I‐Sar 1 , Ile 8 Ang II binding in wild‐type mouse brains was abundant, with highest levels in the molecular layer of the cerebellum, cerebral cortex, hippocampus, amygdala, caudate‐putamen, hypothalamus, lateral septum, and external plexiform layer of the olfactory bulb. Specific 125 I‐Sar 1 , Ile 8 Ang II binding in the neurolysin‐deficient mouse brains was profoundly reduced, however, the extent of reduction was region‐specific. Large decreases were seen in the cerebral cortex, substantia nigra, hippocampus, paraventricular thalamus, lateral septum, nucleus accumbens. Cerebellar cortex and hypothalamus showed moderate reduction in binding. These results confirm neurolysin as the novel non‐AT 1 , non‐AT 2 receptor binding protein, but may reveal additional non‐AT 1 non‐AT 2 binding sites in the mouse brain. Supported by NHLBI HL‐096357